BofA lowered the firm’s price target on Sherwin-Williams (SHW) to $370 from $371 and keeps a Neutral rating on the shares. The firm is updating its price targets for Chemicals under its coverage, the analyst tells investors. Commodities face another year of growing oversupply, specialties continue to manage an inconsistent backdrop, and agriculture presents a more mixed setup, the firm adds. BofA highlights that there are areas for optimism, with several possible catalysts for the stocks including PMI indicators shifting positive, rate cuts, and potential capacity rationalization in China. The firm cautions, however, that these catalysts are too new to rely on.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SHW:
- Sherwin-Williams upgraded to Buy from Hold at Vertical Research
- Sherwin-Williams price target lowered to $390 from $400 at Mizuho
- Citi upgrades Sherwin-Williams to Buy on better setup into 2026
- Sherwin-Williams upgraded to Buy from Neutral at Citi
- Sherwin-Williams: Strong Market Position and Growth Potential Justify Buy Rating
